×
0 0.00215053763440863 0 0.0064516129032259 0.00860215053763453 0.0172043010752689 0.0344086021505377 0.0301075268817206
Stockreport

Biohaven Craters By A Third On Migraine Drug Study Rivaling Allergan [Investor's Business Daily]

ALDER BIOPHARMACEUTICALS INC (ALDR)  More Company Research Source: Investors Business Daily
Last alder biopharmaceuticals inc earnings: 5/8 04:07 pm Check Earnings Report
US:NASDAQ Investor Relations: alderbio.com/investors/investors
PDF Related news 3/23/2018 Track the latest trends and leading stocks in the biotech and pharmaceutical industries. Will This Coming IPO Biotech Undercut Gilead, Novartis In Cancer Drugs? Powerhouse Duo Takes On Gilead, Allergan In Liver Disease, But Stocks Dip Biotech Stock Hit After CEO Suddenly Quits At Critical Juncture Trump Pledges Again To Cut Drug Prices — And Biotech Stocks Ignore Him Why Amgen Shouldn't Use Its War Chest For A Celgene Megamerger How The International Space Station Could Operate Commercially How A Strong Trial From Regeneron Pharma Could Help These Rivals How This Small-Cap Biotech Plans To Chip Away At Amgen's Biggest Drugs Biohaven Pharmaceuticals ( BHVN ) cratered by a third early Monday after it unveiled the results of two late-stage trials for its migraine drug, a competitor to an investigational therapy from Allergan ( AGN ). The drug, called rimegepant , was tested as a treatment for acute migraine. In two [Read more]

IMPACT SNAPSHOT EVENT TIME: ALDR
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS